Furthermore, intra-arterially mesenchymal stem cells therapy in post-stroke facilitates neuroprotection and regulates ER stress-mediated apoptosis via the BDNF/TrkB signaling pathway (Kaur et al., 2021). This evidence concerns the gene BDNF and stroke disorder.